Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 8:40 PM ET


Company Overview of Nascacell Technologies AG

Company Overview

Nascacell Technologies AG is a biotechnology company that develops products and drug development candidates based on the Microbody technology. It provides new generation of biomolecules. The company supports its customers in the areas of target validation and drug discovery through Aptamer and Microbody technologies. It serves pharmaceutical, biotechnology, and other industrial sectors. The company was founded in 2003 and is based in Munich, Germany. As of January 30, 2009, Nascacell Technologies AG is in liquidation.

3 OG Modul D

Max-Lebsche-Platz 31

Munich,  81377


Founded in 2003


49 89 54 72 72 0


49 89 54 72 72 22

Key Executives for Nascacell Technologies AG

Nascacell Technologies AG does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Metanomics GmbH Europe
IMTEC Immundiagnostika GmbH Europe
Wita Proteomics AG Europe
Biochrom GmbH Europe
MorphoSys AbD GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nascacell Technologies AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at